Navigation Links
TrialKit™ Allows Researchers to Easily Employ Core Motion and HealthKit™ on iPhone® and Apple Watch® in Clinical Trials

Crucial Data Solutions (CDS) is excited to announce a real solution to make clinical trial sites and study participants truly unified. TrialKit, a native mobile app, empowers investigators and clinicians to build, deploy, and manage regulatory compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, clinical researchers can utilize Core Motion technologies and Apple’s HealthKit to collect a greater quantity of objective, accurate data in the clinical trial process.

Paul Grady, President of CDS, had this to say, “TrialKit now allows research professionals to accurately measure heart rate, step motion and range of motion. The Apple Watch has completely changed how we think about collecting data from study participants.” Researchers can instantly design a study to collect these and other valuable data points utilizing Core Motion technologies with simple drag-and-drop gestures on a mobile device.

Clinical trials are no longer confined to desktop computers and paper forms. TrialKit leverages the latest in mobile technology with just a few taps on a mobile device. It is capable of everything from integrating activity tests via HealthKit, to using geolocation (GPS) for stamping coordinates on electronic CRFs, collecting image and video files, and utilizing the device’s microphone for dictating data into all fields.

~ One App, No Coding

From a single mobile app, research professionals can build and manage any number of research studies. Other mobile apps are only capable of managing one study within a single instance, making TrialKit an unparalleled system.

TrialKit is a regulatory compliant, out-of-the-box native mobile app, so clinical researchers do not require any programming knowledge or developers to code and configure the app on which they’ll be collecting data. The time and resources saved due to TrialKit’s ready-to-use design result in substantial cost savings, making it appealing to all research teams.

~ Exclusive Certified Native Mobile App for Medical Coding

TrialKit is the only mobile app on the market with medical coding capabilities, providing research professionals with the unprecedented ability to code and approve on-the-go with direct access to MedDRA and WHODrug B3/C3 dictionaries. In addition, csCoder, CDS’ coding solution, is built into TrialKit and designed to ensure data submissions adhere to Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) standards.

~ Optimal Participant Engagement

Electronic participant reported outcomes, or ePRO, allows study participants to quickly and easily complete forms and surveys on their smartphone or tablet, even including photo or video files as needed. Researchers can automate the entire notification process to enforce survey completion with email or in-app push notifications. ePRO is integrated into TrialKit, available on the App Store® today; it will be available on Google Play as TrialKit - Patient for participants to download and use in August.

The next generation of clinical trials can now be executed anytime and anywhere with innovative mobile technology. TrialKit replaces paper source documents with electronic CRFs - resulting in cleaner data than ever before. The removal of paper source documents substantially lowers data entry mistakes as well as trial overhead and study duration.

TrialKit is available for use on Apple® devices now, and will be coming to Android™ this September. Currently, TrialKit is available at no cost for 30 days. Beyond the 30 day trial, the app is $499/month with no limit on sites, users, or studies. For individual researchers, TrialKit is just $99/month, and is always available at no cost to students in support of new researchers worldwide.

About CDS

Crucial Data Solutions, Inc. is a forward-thinking company dedicated to developing innovative technologies that reduce the cost of medical research by equipping clinical professionals with the tools they need to advance treatments that enable patients with life-altering conditions to lead better lives. We believe clinical research should be a true partnership between ourselves, research professionals, caregivers, and patients worldwide.

Google Play is a trademark of Google Inc.
iPhone, Apple Watch, and App Store are registered trademarks of Apple, Inc., registered in the U.S. and other countries.
TrialKit is a trademark of Crucial Data Solutions, Inc.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Innovative New Office For RoviSys Allows Room to Grow
2. Industry Convergence Allows Leading Technology to Enhance Diagnostic and Therapeutic Capabilities
3. Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time
4. Key Mechanism Identified In Pediatric Bone Cancers That Allows Proliferation Of Tumor-Forming Stem Cells
5. InstantGMP’s New Pricing Structure Allows for More Users at the Same Price
6. RAPS Allows Public Access to Regulatory Focus Throughout September
7. AMRESCO’s New Fluorescent DNA Quantitation Kit Uses a Highly Specific DNA-binding Dye that Allows Accurate Quantitation Even in Crude Extracts
8. Groundbreaking New Incubator Technology Allows for Temperature Control at Ambient Conditions (20 to 25C)
9. New IntelLiDrives XYZ Robot helps researchers to study plant development
10. ClearLight Diagnostics and Researchers at the Indiana Universitys Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
11. Researchers Publish Preclinical Data on Reversing Peripheral Neuropathy
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions to ... symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory science, ...
(Date:10/9/2017)... ... 09, 2017 , ... The Giving Tree Wellness Center announces ... needs of consumers who are incorporating medical marijuana into their wellness and health ... As operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):